Riskpilot← Back to searchSign inGet full accessSTERIGENICS DENMARK A/S
A/SActiveCVR 26299691Aa.Louis-Hansens Alle 11Wholesale of pharmaceutical and medical goods · NACE 4646Est. 200147 employees
Revenue 2024
DKK 44,4M
+31% vs 2023
EBITDA margin
73.8%
+36% vs 2023
Equity ratio
90.3%
Financial strength
Net profit 2024
DKK 25,5M
+35% vs 2023
| Revenue | DKK 44,4M | +31% |
| EBITDA | DKK 32,8M | +36% |
| Net profit | DKK 25,5M | +35% |
| Total assets | DKK 76,2M | -40% |
| Equity | DKK 68,9M | -43% |
| Employees | 47 | — |
Legal name
STERIGENICS DENMARK A/S
CVR number
26299691
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
31. oktober 2001
Share capital
DKK 20.001.000
Employees
47 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede bestyrelse eller af bestyrelsesformanden alene eller af et bestyrelsesmedlem i forening med en direktør
Company purpose
Selskabets formål er at udføre kontraktsterilisering hospitaludstyr og andre produkter samt at udføre sådanne andre tjenesteydelser i forbindelse med kontraktsteriliseringen, som for eksempel men ikke begrænset til laboratorium og logistik, import og eksport
Address
Aa.Louis-Hansens Alle 11
Phone
+4549127960
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 13.409 | 13.647 | 13.464 | 14.753 | 17.515 | 21.459 | 28.852 | 20.968 | 23.864 | 33.168 | 37.035 | 34.023 | 44.414 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 5.674 | 5.458 | 5.912 | 7.843 | 9.949 | 14.146 | 21.658 | 14.111 | 17.050 | 25.654 | 26.870 | 24.163 | 32.792 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 5.674 | 5.458 | 5.912 | 7.843 | 9.949 | 14.146 | 21.658 | 14.111 | 17.050 | 25.654 | 26.870 | 24.163 | 32.792 |
| Net financials | -2.800 | -2.399 | -1.814 | -1.154 | -237 | -128 | -63 | -103 | -542 | -251 | -201 | 127 | -87 |
| Profit before tax | 2.874 | 3.059 | 4.098 | 6.689 | 9.712 | 14.018 | 21.595 | 14.008 | 16.508 | 25.403 | 26.669 | 24.290 | 32.705 |
| Tax | -0 | -2.100 | -0 | -2.500 | -1.734 | 1.911 | 4.734 | 3.085 | 3.632 | 5.580 | 5.855 | 5.337 | 7.197 |
| Net profit | 2.874 | 5.159 | 4.098 | 9.189 | 11.445 | 12.107 | 16.861 | 10.923 | 12.876 | 19.823 | 20.814 | 18.953 | 25.508 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 57.537 | 59.712 | 55.184 | 53.473 | 60.993 | 73.947 | 82.643 | 55.476 | 71.340 | 88.451 | 109.488 | 127.288 | 76.247 |
| Equity | 19.423 | 24.581 | 28.679 | 37.868 | 49.313 | 61.420 | 78.282 | 49.205 | 62.081 | 81.903 | 102.717 | 121.670 | 68.865 |
| Long-term debt | 29.332 | 26.029 | 17.006 | 0 | 0 | 0 | 0 | 630 | 2.005 | 0 | 0 | 0 | 0 |
| Short-term debt | 5.517 | 5.078 | 4.684 | 9.998 | 5.236 | 6.083 | 4.361 | 4.463 | 6.383 | 5.912 | 6.314 | 5.401 | 7.121 |
| Total debt | 38.114 | 35.131 | 21.690 | 9.998 | 5.236 | 6.083 | 4.361 | 5.093 | 8.388 | 5.912 | 6.314 | 5.401 | 7.121 |
EBITDA margin
73.8%
This company
15.8%
Market median
+367% vs market
20122024
Equity ratio
90.3%
This company
38.2%
Market median
+136% vs market
20122024
Return on equity
37.0%
This company
18.4%
Market median
+101% vs market
20122024
Net profit margin
57.4%
This company
8.1%
Market median
+609% vs market
20122024
Asset turnover
0.58×
This company
1.12×
Market median
-48% vs market
20122024
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KH Chief Executive Officer | Chief Executive Officer | 2004 | — | — |
MN Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
HJ Chief Executive Officer | Chief Executive Officer | 2003 | — | — |
BI Founder | Founder | 2001 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2001 | — | — | |
| Board of Directors | 2007 | — | — | |
| Board of Directors | 2007 | — | — | |
| Board of Directors | 2004 | — | — | |
| Chairman | 2012 | — | — | |
| Board of Directors | 2003 | — | — | |
| Board of Directors | 2012 | — | — | |
| Chairman | 2003 | — | — | |
| Board of Directors | 2001 | — | — | |
| Board of Directors | 2011 | — | — | |
| Chairman | 2020 | — | — | |
| Chairman | 2025 | — | — | |
| Board of Directors | 2001 | — | — | |
| Board of Directors | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2024 | |
| Individual | 100.0% | 100.0% | 2024 | |
| Individual | 100.0% | 100.0% | 2016 | |
| Individual | 100.0% | 100.0% | 2011 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of STERIGENICS DENMARK A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kim Harboe | Chief Executive Officer | 0 companies |
| Maja Nøddekær | Chief Executive Officer | 0 companies |
| Hans Jozef Maria Aeschlimann | Chief Executive Officer | 0 companies |
| B.V. IBA S&I | Founder | 0 companies |
| Dirk Kanel Lodewijk Barrie | Chairman | 0 companies |
| Verle Catharina A Van de Steen | Board of Directors | 0 companies |
| Eric Hendrik E Meyers | Board of Directors | 0 companies |
| Lucianus Adrianus Christianus M. Bastiansen | Board of Directors | 0 companies |
| Eric Meyers | Chairman | 0 companies |
| James Francis Clauser | Board of Directors | 0 companies |
| Sylvie Schottey | Board of Directors | 0 companies |
| Marc Markey | Chairman | 0 companies |
| Jo Flor Toonn Lambrechts | Board of Directors | 0 companies |
| Eddy Caspers | Board of Directors | 0 companies |
| Lars Pontus Rundström | Chairman | 0 companies |
| Robin Van Der Bergh | Chairman | 0 companies |
| Jean Pierre Andre Francois Miralliè | Board of Directors | 0 companies |
| Ronald Victor Asselberghs | Board of Directors | 0 companies |